Edmond M. Chan

5.9k total citations
7 papers, 655 citations indexed

About

Edmond M. Chan is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Edmond M. Chan has authored 7 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Cancer Research. Recurrent topics in Edmond M. Chan's work include Viral Infectious Diseases and Gene Expression in Insects (3 papers), CRISPR and Genetic Engineering (2 papers) and interferon and immune responses (1 paper). Edmond M. Chan is often cited by papers focused on Viral Infectious Diseases and Gene Expression in Insects (3 papers), CRISPR and Genetic Engineering (2 papers) and interferon and immune responses (1 paper). Edmond M. Chan collaborates with scholars based in United States, United Kingdom and South Korea. Edmond M. Chan's co-authors include Trevor N. Collingwood, Jeffrey C. Miller, Philip D. Gregory, Lin Zhang, Dmitry Guschin, Yolanda Santiago, Michael C. Holmes, Peiqi Liu, Fyodor D. Urnov and Edward J. Rebar and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cell Reports.

In The Last Decade

Edmond M. Chan

7 papers receiving 628 citations

Peers

Edmond M. Chan

MB

IMMUN

GENET

RNMI

ONCOL

Ning-Hsing Yeh Taiwan

Diana Ronai United States

Brian Ondek United States

F Grosveld United Kingdom

Polly E. Mattila United States

Gary Thomas United States

Aribert Stief Germany

Richard Koller United States

S Palmieri United States

S Hashimoto Japan

Ning-Hsing Yeh Taiwan

Edmond M. Chan

452 ×0.8

MB

278 ×2.0

IMMUN

62 ×0.5

GENET

56 ×0.6

RNMI

96 ×1.6

ONCOL

Citations per year, relative to Edmond M. Chan Edmond M. Chan (= 1×) peers Ning-Hsing Yeh

Countries citing papers authored by Edmond M. Chan

Since Specialization

Citations

This map shows the geographic impact of Edmond M. Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edmond M. Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edmond M. Chan more than expected).

Fields of papers citing papers by Edmond M. Chan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edmond M. Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edmond M. Chan. The network helps show where Edmond M. Chan may publish in the future.

Co-authorship network of co-authors of Edmond M. Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Edmond M. Chan. A scholar is included among the top collaborators of Edmond M. Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edmond M. Chan. Edmond M. Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Chan, Edmond M., Kyla Foster, & Adam J. Bass. (2023). WRN Is a Promising Synthetic Lethal Target for Cancers with Microsatellite Instability (MSI). Cancer treatment and research. 186. 313–328. 4 indexed citations

2.

Chan, Edmond M., Tsukasa Shibue, James M. McFarland, et al.. (2019). Abstract LB-048: WRN helicase is a synthetic lethal target in microsatellite unstable cancers. LB–48. 3 indexed citations

3.

Chan, Edmond M., Theodore S. Hong, Jeffrey W. Clark, et al.. (2016). Gemcitabine (G) + nab-paclitaxel (nab-P) versus G in patients (pts) with advanced pancreatic cancer (PDAC) after FOLFIRINOX: A single center, retrospective review.. Journal of Clinical Oncology. 34(4_suppl). 348–348. 2 indexed citations

4.

Tu, Daqi, Zehua Zhu, Alicia Y. Zhou, et al.. (2013). Structure and Ubiquitination-Dependent Activation of TANK-Binding Kinase 1. Cell Reports. 3(3). 747–758. 167 indexed citations

5.

Malphettes, Laetitia, Jennifer Y. Chang, Peiqi Liu, et al.. (2010). Highly efficient deletion of FUT8 in CHO cell lines using zinc‐finger nucleases yields cells that produce completely nonfucosylated antibodies. Biotechnology and Bioengineering. 106(5). 774–783. 124 indexed citations

6.

Liu, Peiqi, Edmond M. Chan, Gregory J. Cost, et al.. (2009). Generation of a triple‐gene knockout mammalian cell line using engineered zinc‐finger nucleases. Biotechnology and Bioengineering. 106(1). 97–105. 81 indexed citations

7.

Santiago, Yolanda, Edmond M. Chan, Peiqi Liu, et al.. (2008). Targeted gene knockout in mammalian cells by using engineered zinc-finger nucleases. Proceedings of the National Academy of Sciences. 105(15). 5809–5814. 274 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact